A microrna contribution to aberrant ras activation in gastric cancer

American Journal of Translational Research

Volumn 3, Issue 2, 2011, Pages 209-218

  Lam, Emily K Y ^a   Wang, Xian ^b   Shin, Vivian Y ^d   Zhang, Shengjie ^a   Morrison, Helen ^c   Sun, Jie ^b   Ng, Enders K O ^d   Yu, Jun ^a   Jin, Hongchuan ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY   (China)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ezrin; Gastric cancer; MiR 204; Ras

Indexed keywords

EZRIN; LUCIFERASE; MICRORNA; MICRORNA 204; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CLINICAL ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH CANCER; UPREGULATION;

EID: 79952921572     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Karnoub AE and Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9: 517-531.
2. Shaw RJ and Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430.
3. Schubbert S, Shannon K and Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007; 7: 295-308.
4. Morrison H, Sperka T, Manent J, Giovannini M, Ponta H and Herrlich P. Merlin/ neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 2007; 67: 520-527.
5. Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P and Ponta H. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell 2007; 18: 76-83.
6. Saleh HS, Merkel U, Geissler KJ, Sperka T, Sechi A, Breithaupt C and Morrison H. Properties of an ezrin mutant defective in F-actin binding. J Mol Biol 2009; 385: 1015-1031.
7. Jin H, Sperka T, Herrlich P and Morrison H. Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature 2006; 442: 576-579.
8. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H and Herrlich P. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001; 15: 968-980.
9. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004; 10: 182-186.
10. Weng WH, Ahlen J, Astrom K, Lui WO and Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005; 11: 6198-6204.
11. Elzagheid A, Korkeila E, Bendardaf R, Buhmeida A, Heikkila S, Vaheri A, Syrjanen K, Pyrhonen S and Carpen O. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 2008;
12. Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK and Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 2008; 52: 738-746.
13. Keates S, Sougioultzis S, Keates AC, Zhao D, Peek RM, Jr., Shaw LM and Kelly CP. cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem 2001; 276: 48127-48134.
14. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003; 3: 877-883.
15. Bretscher A, Edwards K and Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002; 3: 586-599.
16. Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R and Sugiyama T. Infrequent ras mutation in human stomach cancers. Jpn J Cancer Res 1993; 84: 163-167.
17. Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K and Tan D. Morphoproteomic profile of mTOR, Ras/Raf kinase/ ERK, and NF-kappaB pathways in human gastric adenocarcinoma. Ann Clin Lab Sci 2008; 38: 195-209.
18. Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, Cullen PJ and Tao Q. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci U S A 2007; 104: 12353-12358.
19. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS and Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992; 356: 713-715.
20. Kolfschoten IG, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005; 121: 849-858.
21. Croce CM and Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
22. Carthew RW and Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655.
23. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
24. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Rocken C, Ebert MP, Kwok TT and Sung JJ. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009; 101: 699-706.
25. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS and Sung JJ. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
26. Wang X, Lam EK, Zhang J, Jin H and Sung JJ. MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. Biochem Biophys Res Commun 2009; 387: 376-380.
27. Lee RC and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294: 862-864.
28. Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB and Bartel DP. The microRNAs of Caenorhabditis elegans. Genes Dev 2003; 17: 991-1008.
29. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.